BeerYaakov Mental Health Center
17
0
0
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 17 trials
100.0%
+13.5% vs industry average
35%
6 trials in Phase 3/4
0%
0 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (17)
Deep High-Frequency Repetitive Transcranial Magnetic Stimulation for Smoking Cessation
Role: lead
Deep Low-Frequency Repetitive Transcranial Magnetic Stimulation for Cessation of Pathological Gambling
Role: lead
Transcranial Magnetic Stimulation (TMS) in Schizophrenia
Role: lead
Evaluation of the H-Coil Transcranial Magnetic Stimulation(TMS) Device- Augmentation for Drug Resistant Depression
Role: lead
Metformin for Weight Control in Adolescents Taking Atypical Antipsychotics
Role: lead
Escitalopram in Schizophrenia in OCD- Open Label Study
Role: lead
Donepezil Double Blind Trial for ECT Memory Disfunction
Role: lead
Examination of Cognitive Function in Patients Treated With Subutex
Role: lead
Tolerability And Efficacy Of High Dose Escitalopram In The Treatment Of Patients Suffering From Schizophrenia And Obsessive-Compulsive Disorder (OCD) - An Open Label Study
Role: lead
Biological and Cognitive Markers of Violent Behavior in Forensic Patients With Polysubstance Use: Retrospective Evaluation
Role: lead
Development of Population Norms of the Computerized Neuropsychological Assessment for Effectiveness of the Antipsychotic Treatment in Schizophrenia
Role: lead
The Influence of Personality on Two Aspects of Cognitive Performance: Processing Speed, and Accuracy.
Role: lead
Treatment of Neuroleptic Induced Acute Akathisia With Trazodone
Role: lead
Digital Voice Analysis in Patients With Schizophrenia
Role: lead
Assessment of Factors Which Predict Improvement in Children With PDD After a Year of Integrative Therapy
Role: lead
Relationships Between Toddlers With Feeding Disorder and SPD and Their Parents
Role: lead
The Efficacy of Escitalopram for Negative Symptoms in Schizophrenia
Role: lead
All 17 trials loaded